| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |